101. Study protocol : establishment of a multicentre pre-eclampsia database and biobank in Sweden: GO PROVE and UP MOST, a prospective cohort study
- Author
-
Thorgeirsdottir, Lilja, Andersson, Malin, Karlsson, Ove, Thörn, Sven-Egron, Oras, Jonatan, Sengpiel, Verena, Svanvik, Teresia, Elden, Helen, Linden, Karolina, Junus, Katja, Lager, Susanne, Enskär, Ida, van Veen, Teelkien, Wikström, Johan, Björkman-Burtscher, Isabella, Stigsdotter Neely, Anna, Wikström, Anna-Karin, Bergman, Lina, Thorgeirsdottir, Lilja, Andersson, Malin, Karlsson, Ove, Thörn, Sven-Egron, Oras, Jonatan, Sengpiel, Verena, Svanvik, Teresia, Elden, Helen, Linden, Karolina, Junus, Katja, Lager, Susanne, Enskär, Ida, van Veen, Teelkien, Wikström, Johan, Björkman-Burtscher, Isabella, Stigsdotter Neely, Anna, Wikström, Anna-Karin, and Bergman, Lina
- Abstract
Introduction Pre-eclampsia, a multisystem disorder in pregnancy, is one of the most common causes of maternal morbidity and mortality worldwide. However, we lack methods for objective assessment of organ function in pre-eclampsia and predictors of organ impairment during and after pre-eclampsia. The women’s and their partners’ experiences of pre-eclampsia have not been studied in detail. To phenotype different subtypes of the disorder is of importance for prediction, prevention, surveillance, treatment and follow-up of pre-eclampsia. The aim of this study is to set up a multicentre database and biobank for pre-eclampsia in order to contribute to a safer and more individualised treatment and care. Methods and analysis This is a multicentre cohort study. Prospectively recruited pregnant women ≥18 years, diagnosed with pre-eclampsia presenting at Sahlgrenska University Hospital, Uppsala University Hospital and at Södra Älvsborgs Hospital, Sweden, as well as normotensive controls are eligible for participation. At inclusion and at 1-year follow-up, the participants donate biosamples that are stored in a biobank and they are also asked to participate in various organ-specific evaluations. In addition, questionnaires and interviews regarding the women’s and partner’s experiences are distributed at follow-up. Ethics and dissemination By creating a database and biobank, we will provide the means to explore the disorder in a broader sense and allow clinical and laboratory discoveries that can be translated to clinical trials aiming at improved care of women with pre-eclampsia. Further, to evaluate experiences and the psychological impact of being affected by pre-eclampsia can improve the care of pregnant women and their partners. In case of incidental pathological findings during examinations performed, they will be handled in accordance with clinical routine. Data are stored in a secure online database. Biobank samples are identified through the women’s personal identificat
- Published
- 2021
- Full Text
- View/download PDF